BP11146 PLGA 65:35, Hydroxyl Terminated, IV: 0.65–0.8 dl/g, Mw: 88–117 kDa

PLGA 65:35, Hydroxyl Terminated, IV: 0.65–0.8 dl/g, Mw: 88–117 kDa Description

PLGA (polylactic-co-glycolic acid) 65:35, Hydroxyl Terminated is a copolymer where the lactic to glycolic acid ratio is 65:35. Its specified intrinsic viscosity and molecular weight range dictate the degradation behaviour and mechanical integrity, making it suitable for applications that necessitate a specific temporal profile in erosion or drug release. The hydroxyl end groups allow for further chemical modifications to tailor surface properties.

PLGA 65:35, Hydroxyl Terminated, IV: 0.65–0.8 dl/g, Mw: 88–117 kDa Applications

1.         Healthcare Applications
   - Used as a scaffold component in tissue engineering to achieve controlled cell growth by leveraging its predictable degradation rate.
   - Applied as a drug delivery matrix in implantable devices to enable sustained therapeutic release through gradual polymer erosion.

2.         Industrial Applications
   - Employed as a biodegradable binder in environmentally sensitive manufacturing processes to minimise residue by utilising its hydrolytic degradation characteristics.
   - Used as a temporary structural component in bioresorbable packaging to facilitate eventual material breakdown and reduce waste.

PLGA 65:35, Hydroxyl Terminated, IV: 0.65–0.8 dl/g, Mw: 88–117 kDa Packing

The product is securely packaged in inert, moisture-resistant foil pouches to mitigate contamination and environmental exposure. Each pouch is sealed within rigid secondary packaging to protect against physical stress. Storage is recommended in a cool, dry location to preserve polymer characteristics. Custom packaging options may include temperature-controlled containers and tamper-evident seals based on specific customer requirements.

Additional Information

Biodegradable polymers like PLGA play a significant role in modern material science due to their predictable hydrolysis profiles and ease of modification. Their degradation products are typically metabolised naturally, providing a safe pathway for biomedical applications.
Understanding the structure-property relationship in copolymers is critical. The lactic to glycolic acid ratio, along with terminal functional groups, influence mechanical strength, hydrophilicity, and degradation kinetics, thereby expanding their usability in both industrial and healthcare applications.

Regulatory Note: This material is intended for industrial and research applications. It is the customer's responsibility to ensure compliance with all relevant safety and regulatory standards in their intended use.